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Abstract 
Nonsense-mediated mRNA decay (NMD) has traditionally been described as a quality control 
system that rids cells of aberrant mRNAs with crippled protein coding potential. However, 
transcriptome-wide profiling of NMD deficient cells identified a plethora of seemingly intact 
mRNAs coding for functional proteins as NMD targets. This led to the view that NMD constitutes 
an additional post-transcriptional layer of gene expression control involved in the regulation of 
many different biological pathways. Here, we review our current knowledge about the role of 
NMD in embryonic development and tissue-specific cell differentiation.  We further summarize 
how NMD contributes to balancing of the integrated stress response and to cellular homeostasis 
of splicing regulators and NMD factors through auto-regulatory feedback loops. In addition, we 
discuss recent evidence that suggests a role for NMD as an innate immune response against 
several viruses. Altogether, NMD appears to play an important role in a broad spectrum of 
biological pathways, many of which still remain to be discovered. 
Keywords: RNA turnover; posttranscriptional gene regulation, mRNA surveillance; NMD; 
neuronal differentiation; spermatogenesis; unfolded protein response; stress response; UPF1, 
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 1. Introduction 
 
In eukaryotes, nonsense mutations truncate the open reading frame (ORF) of genes 
prematurely and have long been known to reduce the half-life of the respective mRNA [1, 2]. 
This widespread phenomenon has been termed nonsense-mediated mRNA decay or NMD for 
short [3]. Genetic screens in Saccharomyces cerevisiae and Caenorhabditis elegans identified 
the first proteins required for NMD [4, 5] and since then homologous proteins have been 
identified in most other eukaryotic organisms. More recently, additional NMD factors were 
identified in C. elegans [6] [7] [8] and human cells [9]. 
Despite a wealth of biochemical data documenting interactions between the different 
NMD factors, the exact molecular mechanism of NMD is not yet understood. There is an 
emerging consensus, however, that NMD results from improper translation termination at 
stop codons occurring in places of the mRNP that lack necessary termination stimulating 
signals and/or contain termination inhibitors. It is likely that in mammalian cells many 
regulators of translation termination exist, however functional data is currently available for 
only a few. The most well understood is the major cytoplasmic poly(A) binding protein 
(PABPC1), which acts as a potent NMD suppressor when bound in the vicinity of the stop 
codon [10] [11]. Whether “improper” termination means that those translation events that 
trigger NMD are mechanistically different from those that leave the mRNA intact, or whether 
it is only slower termination that gives enough time for the assembly of an NMD complex and 
subsequent mRNA degradation, is currently unresolved. The observation that UGA stop 
codons that normally code for selenocysteine elicit NMD under limiting selenium 
concentrations [12] [13] supports the current model postulating that NMD results from 
prolonged ribosome stalling at stop codons due to the absence of termination promoting 
signals. Slow or stalled translation termination allows the core NMD factor UPF1 – an ATP-
dependent RNA helicase – and the SMG1 complex to interact via the release factors eRF1 and 
eRF3 with the stalled ribosome [14]. Interaction of UPF2 and possibly UPF3B with the SMG1-
UPF1 complex activates the SMG1 kinase, resulting in the phosphorylation of several serine-
glutamine (SQ) and threonine-glutamine TQ motifs in the N and C-terminal part of UPF1 that 
flank its helicase domain. The endonuclease SMG6 [15, 16] and the heterodimer SMG5/SMG7 
have been found to interact with phosphorylated UPF1 [17] and to induce the degradation of 
the targeted mRNA. Recent evidence suggests that in human cells NMD is predominantly 
initiated through a SMG6-mediated endonucleolytic cleavage near the stop codon [18, 19] 
and as a backup system through SMG7-mediated recruitment of the CCR4/NOT complex, 
which deadenylates the mRNA, leading to decapping followed by 5’-to-3’ exonucleolytic 
degradation by XRN1 [20]. 
Interestingly, it seems that not all proteins known to be required for NMD in 
mammalian cells  have homologues in other organisms [21] (Table 1), indicating that  
differences in the regulation and maybe even in the molecular mechanism of NMD among 
different species are very likely to exist. For example, no homologues of the serine/threonine 
protein kinase SMG1 and its regulators SMG8 and SMG9 appear to be present in S. cerevisiae. 
Given that SMG1-mediated phosphorylation of the central NMD factor UPF1 represents a 
crucial step in NMD in a majority of organisms, it remains unclear whether S. cerevisiae has 
developed an alternative phosphorylation-independent way of activating NMD or whether a 
different yet unknown kinase fulfills this function. That a few phosphorylation sites present in 
mammalian UPF1 are conserved in S. cerevisiae Upf1 would argue for the latter possibility 
[22]. SMG1 is also absent from Arabidopsis thaliana, while SMG1 homologues are found in all 
other examined plants [23], raising the intriguing question of how A. thaliana could afford to 
lose SMG1 during plant evolution without simultaneously incapacitating NMD. It is not only 
the SMG1 complex that is missing in some species; homologues of the mammalian 
SMG5/SMG7 heterodimer and of SMG6 are also absent in some eukaryotes. For example, 
Drosophila melanogaster lacks a SMG7 homologue and NMD appears to be induced 
exclusively by SMG6-mediated endonucleolytic cleavage of the mRNA in flies. No homologues 
of SMG5, SMG6 and SMG7 have been unambiguously identified in S. cerevisiae, although 
there is some evidence that the protein Ebs1 might be the orthologue of SMG7 [24]. Overall 
it looks as if NMD comes in different flavours in different organisms, with only UPF1, UPF2 and 
UPF3 forming the evolutionarily conserved core. 
Since the focus of this review is on the biological processes in which NMD plays a 
critical role in shaping the respective gene expression program rather than on the mechanistic 
aspects of NMD, we decided to provide only a brief sketch of the current mechanistic NMD 
model in mammalian cells. Several recent reviews describe in much greater detail the current 
working models and open mechanistic questions, and readers interested in the mechanism of 
NMD are referred to these publications [25-27]. Among these many open questions, one of 
the most pressing is to better understand the translation termination conditions that result in 
NMD and how they differ from the conditions required for proper termination. It was 
discovered early on that the presence of an exon-exon junction located >50 nucleotides 
downstream of the stop codon was a hallmark of mammalian mRNAs subject to NMD [28]. 
Rather than being strictly required for NMD, however, it was later found that these exon-exon 
junctions function as enhancers of NMD efficacy (i.e. leading to a more pronounced 
destabilization of the mRNA) and that long 3’ UTRs lacking exon-exon junctions can also trigger 
NMD [29] [10] [30]. Similar to long 3’ UTRs, short upstream ORFs (uORFs) and ORF-interrupting 
premature termination codons (PTCs) are also well known NMD-inducing features that result 
in ribosomes terminating translation distantly from the poly(A) tail. Transcriptome profiling 
revealed that NMD modulates the cellular abundance of many mRNAs that appear to code for 
full length functional proteins [31] [32] [33] [34] [35], indicating that beyond its well 
documented quality control function, NMD also contributes to regulating gene expression and 
therewith is likely to play an important role in the regulation of specific biological pathways. 
In the following, we review our current knowledge about the different biological functions of 
NMD. 
  
2. NMD factors are essential for normal embryonic development and viability  
NMD factors have an essential role in mammalian embryogenesis, since the knockout of 
almost every one of these genes is embryonic lethal. For instance, UPF1 knockout (KO) mice 
are only viable in the pre-implantation period (up to embryonic day 3.5 [E3.5]), and attempts 
to maintain the UPF1-/- pre-implantation blastocysts in culture have failed due to a strong 
induction of apoptosis [36]. Similarly, UPF2 KO mice die in utero between E3.5 and E9.5 [37]. 
Efforts to generate SMG1 KO mice also resulted in developmental arrest at E8.5, with SMG1-
/- embryos showing profound developmental defects [38]. Alike UPF1-/- mice, SMG6 KO mice 
also die around the implantation period, due to impaired differentiation of SMG6-/- cells [39]. 
Very recently, embryonic lethal phenotypes were also reported for UPF3A and SMG9 deficient 
mice. UPF3A KO mice die between E4.5 and E8.5 [40]. In the case of SMG9, E15.5 homozygous 
embryos with a severe hypomorph SMG9 allele showed a range of variable and incompletely 
penetrant phenotypes including hemorrhage, and exencephaly [41]. To date, the only 
reported constitutive KO of an NMD factor that is viable in mice is UPF3B [42]. Even though 
UPF3B KO mice have no overt phenotypic defects, UPF3B mutations have been found in 
humans with a wide range of intellectual disabilities [43, 44] [45] [46] [47], implying that 
UPF3B might be required for normal neuronal development and/or function (see section 3.2). 
There is evidence that some NMD factors function in additional cellular pathways apart 
from NMD. For example, UPF1 is involved in telomere maintenance, cell cycle progression and 
degradation of histone mRNAs (reviewed in [48]) and SMG1 and SMG6 were also reported to 
play a role in telomere maintenance [49]. Even though their loss results in embryonic lethality, 
it still remains to be elucidated if this can be attributed to inhibition of the NMD pathway per 
se, or if, alternatively, all these KOs converge into similar phenotypes as a consequence of the 
inactivation of their non-NMD roles. There is evidence suggesting that NMD inactivation is 
responsible for the observed developmental defects. While SMG6 KO mice are inviable, SMG6 
KO mouse embryonic stem cells (mESC) can be generated and cultured in vitro [39]. SMG6 
deficient mESCs can proliferate normally and are indistinguishable from control mESCs, but 
they fail to differentiate into all three germ layers (Fig. 1). Attempts to rescue SMG6-/- mESCs 
with either NMD-deficient or telomere maintenance-deficient mutant forms of SMG6 showed 
that only the expression of NMD-proficient versions of SMG6 relieved the differentiation block 
of SMG6-/-  mESCs [39]. 
Since NMD regulates the levels of many endogenous transcripts, it can be envisioned 
that it is the upregulation of one or several specific transcripts that renders the KO of NMD 
factors inviable, and not the massive accumulation of faulty transcripts, as originally thought. 
In the case of the differentiation blockade in mice upon SMG6 KO, it was demonstrated that 
c-Myc mRNA is targeted by NMD and that elevated c-Myc is responsible for keeping the SMG6-
/- mESC from differentiating in vitro [39]. More evidence to support this notion came from a 
suppressor screen in Drosophila melanogaster seeking to restore viability of a NMD mutant, 
where they found that deletion of the Gadd45 coding region restored full viability to Upf225G 
mutants (a partially viable, hypomorphic Upf2 allele), and partially suppressed the complete 
lethality observed in Upf1 and Upf2 null mutants [50]. The authors could show that NMD 
deficient flies have increased levels of cell death and this is suppressed by Gadd45 elimination. 
Similarly, Gadd45b knockdown was shown to partially rescue the reduction in cell viability 
observed following Upf1 knockdown in mammalian cells. These results suggest that the 
upregulation of Gadd45 is an important contributor – although probably not the only one –  
to lethality upon NMD inactivation [50].  
Additional evidence that NMD can influence very early developmental decisions comes 
from a study in human embryonic stem cells (hESCs). Lou and colleagues showed that UPF1 
depletion altered the expression of genes involved in several major signaling cascades and 
suggested that NMD promotes the differentiation of hESCs into mesoderm and inhibits their 
differentiation into definitive endoderm by regulating the balance between TGF-β and BMP 
signaling (Fig. 1) [51]. 
 
3. Roles for NMD factors in tissue-specific differentiation programs 
Conditional knockout (cKO) strategies were used to overcome the early embryonic lethality 
and study the roles of NMD factors at later stages during development, in a tissue-specific 
manner. Induced deletion of UPF2 in the hematopoietic system resulted in complete loss of 
hematopoietic stem and progenitor cell populations and death of the cKO mice (Fig. 1). 
However, UPF2 deletion in the myeloid lineage had no phenotypic consequences, suggesting 
that UPF2 has a vital role in proliferating, but not terminally differentiated, cells [37]. On the 
other hand, conditional ablation of UPF2 from the developing liver is incompatible with 
postnatal life due to failure of terminal differentiation. Furthermore, UPF2 is required for adult 
normal liver homeostasis and liver regeneration [52]. 
 
3.1 Tight regulation of NMD activity is required for normal spermatogenesis 
Several lines of evidence support a role for NMD in germ cell development and male fertility 
(Fig. 2). Conditional ablation of UPF2 from embryonic Sertoli cells (SC) – somatic cells that 
nourish sperm cells through spermatogenesis – in mice leads to testicular atrophy and male 
sterility due to depletion of SC and germ cells (GC) [53]. RNA-seq analysis of total testis 
revealed that UPF2 deletion causes a transcriptome-wide dysregulation of gene expression, 
with approximately 30% of the upregulated genes containing a stop codon >50 nucleotides 
upstream of an exon-exon junction (Fig. 2B) [53]. More recently, Bao and colleagues studied 
the role of UPF2 in GC. They generated two different UPF2 cKO mice: prospermatogonia-
specific UPF2 cKO and spermatocyte-specific UPF2 cKO. In both cases, they found that adult 
UPF2 cKO males were infertile, exhibited a drastic reduction in testis size and that UPF2 cKO 
seminiferous tubules were almost completely devoid of GC (Fig. 2C) [54]. These two cKO 
studies show that UPF2 is essential not only for the first wave of spermatogenesis during 
testicular development but also for the subsequent spermatogenic cycles in adult testes [54]. 
Surprisingly, transcriptome profiling showed that UPF2 cKO spermatocytes and round 
spermatids had a selective upregulation of transcripts with long 3’UTRs, whereas the classical 
NMD targets (those that harbor an exon-exon junction >50 nucleotides downstream of the 
termination codon) were not affected [54]. UPF1 and UPF2 are highly expressed in post-
meiotic germ cells and they are localized in germ cell-specific perinuclear granules called 
chromatoid bodies (CBs) [55]. While studying the function of Tudor domain-containing protein 
6 (TDRD6) in CBs, Fanourgakis and colleagues found that in the absence of TDRD6, UPF1 fails 
to localize to CBs and can no longer interact with UPF2. Resembling the phenotype observed 
for UPF2 cKOs, TDRD6-/- spermatocytes and round spermatids show a specific accumulation 
of transcripts with long 3’UTRs (Fig. 2E) [55]. Taken together, these studies support the notion 
that in GC, transcripts with long 3’UTRs are targeted by NMD in a UPF2 and CB-dependent 
manner, whereas degradation of transcripts harboring an EJC in the 3’UTR is UPF2 and CB-
independent. In mice, the testis is the only adult tissue with high UPF3A protein expression 
and recent evidence suggests that UPF3A can work as an NMD repressor that sequesters UPF2 
from NMD substrates [40]. UPF3A cKO in meiotic GC resulted in mice with reduced sperm 
counts characterized by loss of later-stage GC. Consistent with UPF3A acting as a NMD 
repressor, many NMD substrate RNAs were downregulated in UPF3A cKO spermatocytes, 
when compared to controls (Fig. 2D) [40]. Altogether, these studies highlight the importance 
of a tight control of NMD efficiency to sustain normal spermatogenesis. 
 
3.2 NMD factors are required for neuronal development and physiology 
There is some indication that downregulation of NMD activity is required for neural 
differentiation. Lou and colleagues found that the levels of many NMD factors, and 
consequently NMD efficiency, are reduced during in vitro neural differentiation of mouse 
neuronal stem cells (mNSCs) and human neural progenitor cells (hNPCs) [56]. Forced 
maintenance of UPF1 expression levels in differentiating P19 cells blocked retinoic acid (RA)-
induced neuronal differentiation, whereas UPF1 knockdown triggered neuronal 
differentiation in the absence of RA (Fig. 1) [56]. Analysis of UPF1-depleted P19 cells revealed 
that some proliferation inhibitors and pro-neural factors are direct NMD targets, providing a 
molecular basis for the role of UPF1 in sustaining the stem cell state and antagonizing neural 
differentiation [56]. miR-128 is a brain-specific miRNA whose expression is dramatically 
increased during neural differentiation both in vivo and in vitro and UPF1 is a direct target of 
miR-128 [57]. miR-128 and Upf1 RNA levels are inversely correlated during neuron maturation 
and differentiation in vitro and during brain development in vivo [56, 57]. Lou and colleagues 
found evidence that in addition to miR-128 repressing UPF1 levels, NMD activity can indirectly 
downregulate the levels of miR-128. This mutually repressive circuit is predicted to lock the 
cells in either an undifferentiated (with high NMD activity) or differentiated (with low NMD 
activity) state (Fig. 3A) [56]. Remarkably, the UPF1/miR-128 circuit is conserved and controls 
cell proliferation and differentiation in Xenopus laevis [56]. 
NMD has further been reported to influence commissural axonal pathfinding in the 
spinal cord [58]. Normal commissural axon guidance depends on the expression of two 
alternatively spliced isoforms of the ROBO3 receptor, ROBO3.1 and ROBO3.2. The latter 
retains an intron that contains a stop codon, and is predicted to be an NMD target. Axonal 
growth cones are initially attracted towards the midline floor plate, in a ROBO3.1-dependent 
manner. After crossing the midline, axons are repelled from the floor plate and this switch is 
accompanied by a sharp induction of ROBO3.2 expression. Colak and colleagues found that 
ROBO3.2 mRNA is present in pre-crossing commissural axons in a translation repressed state 
that renders it NMD-resistant. After crossing the midline, floor plate signals induce local 
translation of ROBO3.2 and allow NMD to ensue on the transcript. Neural growth cones of 
commissural neurons are enriched in UPF1, UPF2 and SMG1 proteins. When UPF2 was 
selectively ablated from spinal commissural neurons, increased levels of ROBO3.2 mRNA and 
protein were observed in post-crossing axons, and this lead to abnormal axon guidance, 
characterized by increased repulsion from the floor plate [58]. In addition, other transcripts 
of the Robo family were shown to be upregulated upon NMD impairment, further supporting 
a role for NMD in axon guidance [57, 59]. 
 
4. NMD is involved in the integrated stress response  
Several stress-associated mRNAs are targeted by NMD in unstressed cells [18, 32, 35]. 
Interestingly, many of them escape NMD degradation upon ER stress, amino acid starvation 
and hypoxia [60-64]. One such transcript is the one encoding the activating transcription 
factor 4 (ATF4). ATF4 is the best characterized effector of the integrated stress response (ISR), 
an adaptive signaling pathway present in eukaryotes that is activated in response to diverse 
stress stimuli. Activation of ISR leads to phosphorylation of eIF2α and to a global attenuation 
of cap-dependent translation with a concomitant increase in translation of selected stress-
related mRNAs [65]. In unstressed cells, ATF4 mRNA is subjected to NMD degradation because 
it contains several uORFs in its 5’ UTR. However, upon eIF2α phosphorylation, the main ORF 
in ATF4 mRNA is translated and ATF4 protein accumulates [66, 67]. ATF4 increase results in 
the activation of a gene expression program that promotes cellular recovery. 
By downregulating stress-responsive genes in unstressed cells, NMD activity may 
prevent the triggering of a stress response upon innocuous stimuli. However, following 
exposure to strong stressors, specific mRNAs can evade NMD and are upregulated as part of 
the stress response. In support of this view, a bi-directional control between NMD and the 
unfolded protein response (UPR) was recently reported [60]. The UPR is an adaptive 
intracellular mechanism that is activated when misfolded or unfolded proteins accumulate in 
the lumen of the ER. Activation of the UPR results in changes in the transcriptional and 
translational landscape of the cell, aimed at restoring ER homeostasis. When this is 
accomplished, the UPR is inactivated, to avoid programmed cell death that otherwise follows 
prolonged ER stress [68]. Karam and colleagues found that many mRNAs encoding UPR 
components are targeted by NMD, including the conserved ER stress transducer IRE1α. Using 
loss-of-function studies, the authors showed that NMD-deficiency results in exacerbated UPR 
activation upon normally innocuous levels of ER stress, suggesting that NMD activity increases 
the threshold of stress required to trigger the UPR [60]. In addition, NMD activity was found 
to be important during the termination phase of UPR, to attenuate the UPR and protect the 
cells from ER stress-induced apoptosis. Not only can NMD repress the UPR, the UPR can also 
inhibit NMD by promoting eIF2α phosphorylation [60]. This establishes a bi-directional circuit 
in which NMD represses UPR activation after harmless ER stress while, upon strong ER stress, 
the UPR represses NMD to allow a robust stress response (Fig. 3B). In support of this feedback 
loop, Sieber and colleagues uncovered that NMD inhibition induces the upregulation de novo 
protein synthesis of downstream targets of the PERK and IRE1 branches of the UPR [69], 
whereas Li and colleagues found that thapsigargin treatment, which induces ER stress, inhibits 
NMD via activation of the PERK branch of the UPR [61]. 
Autophagy is a surveillance mechanism that rids the cells of cytoplasmic deleterious 
proteins and also serves as a source of amino acids during metabolic stress. Many cellular 
stressors, like amino acid deprivation and hypoxia, inhibit NMD and activate autophagy, and 
an inverse correlation between these two pathways was reported [70]. Inhibition of NMD 
activates autophagy, in a partially ATF4-dependent manner, and increases intracellular amino 
acid levels, while NMD hyperactivation blunts stress-induced autophagy [70]. 
Furthermore, NMD is also involved in the mitigation of oxidative stress [63]. SLC7A11 
is a subunit of the xCT cysteine/glutamate amino acid transport system, and its mRNA is a 
NMD target whose expression is upregulated in response to cellular stress [63]. The authors 
showed that NMD inhibition by stress-induced eIF2α phosphorylation leads to stabilization of 
SLC7A11, increase in intracellular glutathione levels and establishment of an adaptive 
response to oxidative stress. 
It was recently reported that NMD inhibition is also part of the pro-apoptotic response 
to stress [71, 72]. UPF1 and UPF2 are cleaved by caspases upon apoptotic insults, and the 
respective truncated proteins have dominant negative effects. Their expression leads to 
upregulation of NMD targets and to induction of apoptosis [71, 72]. This suggests that after 
an apoptotic insult, NMD inhibition and caspase-induced UPF fragments reinforce the 
apoptotic response. Finally, it should be noted that some NMD factors, for example SMG1 and 
SMG7, play roles in the DNA damage response that seem to be independent of NMD [73, 74]. 
 
5. RNA viruses are targeted by or able to evade the host NMD machinery 
The multicistronic nature of viral genomes introduces features into their transcripts that could 
trigger the host NMD pathway. In particular, the presence of uORFs results in stop codons in 
positions in which they would be expected to activate NMD. Similarly, translation of the first 
ORF of the genome of a plus-strand RNA virus resembles the situation of translating an mRNA 
with a long 3’ UTR, another feature that may elicit NMD. Indeed, a number of studies 
demonstrating the degradation of viral transcripts by NMD have come to light, suggesting that 
NMD could represent part of the host cell innate immune response. Such studies have been 
done in plants, insects, as well as mammalian cell systems. In plants, it was shown that NMD 
targets two subgenomic RNAs – both with long 3’ UTRs – of potato virus X (PVX) and that 
restriction by NMD was dependent on the length of the 3’ UTR [75]. In addition, NMD 
suppression in tobacco plants led to an increase in Turnip Crinkle Virus (TCV) genomic RNA 
[75]. The NMD factors, UPF1, SMG5 and SMG7 were shown to be involved in restricting viral 
replication of two alphaviruses, Semliki Forest Virus (SFV) and Sindbis Virus (SINV), in 
mammalian cells [76]. Surprisingly, shortening of the 3’ UTR of SFV still rendered the viral 
genome sensitive to NMD [76]. The mechanism by which NMD recognizes and degrades the 
SFV genome therefore remains unclear. 
Since viral genomes present targets for NMD, it is unsurprising that viruses have 
evolved mechanisms to protect them from degradation by the host cell NMD machinery. For 
example, Hepatitis C Virus (HCV) was shown to inhibit NMD in hepatoma cell lines [77]. 
Although the complete mechanism remains unclear, NMD inhibition by HCV infection was 
thought to involve the direct interaction found between the HCV core protein and the EJC 
recycling factor PYM [77]. Mechanisms to evade NMD have also been reported for a number 
of retroviruses, including Human T-lymphotropic Virus Type 1 (HTLV-1), Rous Sarcoma Virus 
(RSV), and Moloney Murine Leukemia Virus (MoMLV), [78-82]. HTLV-1 encodes viral proteins 
(TAX and REX) that were demonstrated to inhibit NMD by binding and sequestering 
components of the pathway [78, 83]. Resistance of RSV to NMD was found to be conferred by 
a 400 nucleotide stretch, containing 11 CU-rich clusters, termed the RSV RNA stability element 
(RSE) [79, 80]. The RSE, located immediately downstream of the stop codon of the first ORF 
(gag), was found to be a binding site for PTBP1 [81]. Ge and colleagues showed that PTBP1 
binding to the RSE prevents recruitment of UPF1, thereby inhibiting NMD, and further 
demonstrated that insertion of PTBP1 binding sites downstream of the stop codon was 
sufficient to rescue NMD-sensitive cellular mRNAs from degradation [81].  
Proper viral assembly of MoMLV, as for all retroviruses, requires a balance between 
the production of polyproteins (encoded by the Gag gene) and viral reverse transcriptase (RT) 
(encoded by a Gag-Pol fusion protein). In the MoMLV genome, the Gag and Pol genes are 
encoded in the same reading frame, separated by a UAG stop codon [82]. To allow controlled 
expression of the Pol gene, MoMLV uses strategies to suppress the stop codon between the 
two genes, thereby promoting read-through. One such strategy is the presence of an RNA 
pseudoknot downstream of the UAG stop codon [84, 85]. A recent study that determined the 
crystal structure of MoMLV RT in complex with full length mouse eukaryotic release factor 1 
(eRF1) followed by functional assays, revealed that the binding of MoMLV RT to eRF1 
competitively inhibits binding of eRF3, thereby suppressing translation termination and 
promoting read-through [82]. Using a dual-fluorescent reporter system, the authors 
demonstrated that the RNase H domain of MoMLV RT enhanced read-through above RNA 
pseudoknot-directed read-through [82]. In addition, mRNA decay assays revealed that the 
RNase H domain of MoMLV RT was also involved in mRNA stability, suggesting that it has a 
protective role against NMD. The authors noted that since UPF1 interacts with eRF1 and eRF3 
to trigger NMD [11, 86], disruption of the interaction of UPF1 with this complex, by MoMLV 
RT binding, could be the mechanism by which the viral mRNA is protected from the NMD 
machinery [82]. 
Intriguingly, a number of reports have shown that HIV, in contrast to the above-
mentioned studies, requires UPF1 for infectivity and nuclear export of viral RNA [87-89]. The 
role of UPF1 in HIV infection was shown to be independent of UPF2, indicating an NMD-
independent role for UPF1 in promoting HIV infectivity [87]. 
 
6. Alternative splicing coupled with NMD (AS-NMD) modulates post-transcriptional gene 
expression 
Mammalian cells employ extensive alternative pre-mRNA splicing to generate multiple mRNA 
isoforms produced from a single gene. Differentially spliced mRNA isoforms may give rise to 
changes in protein structure and function, thereby contributing to organism- or tissue-specific 
proteome diversity. However, differential splicing may also generate transcript isoforms with 
PTCs, which are recognized and degraded by NMD. 
Many RNA binding proteins, including splicing regulators themselves, use AS-NMD as 
a mechanism to regulate their own abundance in a homeostatic feedback loop. This was 
shown for most SR proteins in a number of independent studies [18, 90, 91]. Additionally, 
many hnRNPs were also suggested to be autoregulated by AS-NMD via homeostatic feedback 
loops [91]. For example, Rossbach and colleagues demonstrated that inclusion of exon 6a in 
human hnRNP L introduces a PTC, rendering the isoform sensitive to NMD [92]. Binding of 
hnRNP L to an intronic region immediately upstream of exon 6a promotes inclusion of exon 
6a. An excess of hnRNP L therefore triggers NMD of its own mRNA [92]. Polypyrimidine tract 
binding protein (PTB), an important regulator of alternative splicing, presents another 
example of autoregulation by AS-NMD. High levels of PTB promotes exon 11 skipping, which 
results in an NMD-sensitive PTB isoform [93]. 
PTB proteins also regulate alternative splicing events of other mRNA transcripts, some 
of which produce isoforms susceptible to NMD [94, 95]. Such is the case for HPS1, a subunit 
of a guanine nucleotide exchange factor (GEF) essential for biogenesis of lysosome-related 
organelles. The strong correlation of expression levels of HPS1 and PTB protein 1 (PTBP1) 
across mammalian tissues is indicative of this regulatory circuit [94]. Similarly, PTBP1 levels 
regulate alternative splicing of PSD-95, a postsynaptic scaffold protein important in 
glutamatergic synapses in neurons [95]. High levels of expression of PTBP1 and PTBP2 in non-
neural cells result in exon 18 skipping, causing a frameshift and hence a PTC in exon 19, 
thereby rendering this transcript isoform sensitive to NMD. This results in low levels of 
abundance of functional PSD-95 in non-neural cells [95]. The proportion of exon 18 inclusion 
was shown to increase upon differentiation of hESCs into hNPCs and then into neurons, 
suggesting that PSD-95 exon 18 inclusion, and hence functional PSD-95 expression, is neural-
specific in human cells [95]. Several other studies have also reported a role for AS-NMD in 
regulating cellular differentiation programs [96-98]. 
More recently, proteins involved in chromatin modification were also identified as 
being regulated by AS-NMD. This was revealed through deep RNA-sequencing analysis of 
highly conserved AS-NMD exons between human and mouse brain cortex [99]. In line with 
this, a recent study revealed that expression of Chromatin target of PRMT1 (Chtop) is 
regulated by AS-NMD via an autoregulatory homeostatic feedback loop (Fig. 3C) [100]. Chtop 
was shown to bind its own mRNA to control retention of intron 2 during splicing. Retention of 
intron 2 results in a PTC, which renders Chtop mRNA susceptible to NMD [100]. It is important 
to note that AS-NMD has also been reported in non-mammalian systems, including plants 
[101], zebrafish [102] and S. cerevisiae [103]. As functional and mechanistic evidence for AS-
NMD continues to emerge, it is becoming clearer that AS-NMD is a biologically relevant post-
transcriptional mechanism that fine-tunes gene expression by modulating the overall 
abundance of functional protein coding isoforms. 
 
7. NMD factors are autoregulated by the NMD pathway 
Independent studies by Huang and colleagues [42] and Yepiskoposyan and colleagues [34] 
revealed that suppression of NMD by NMD factor knockdowns resulted in a significant 
increase in NMD factor mRNA levels of UPF1, UPF2, UPF3B, SMG1, SMG5, SMG6 and SMG7. 
An autoregulatory feedback loop for the regulation of NMD factors by NMD was thus 
identified. All seven NMD factor mRNAs that were identified possess long 3‘ UTRs, and some 
possess uORFs [34, 42]. The 3’ UTRs of UPF1, SMG5, SMG7 and the uORF of SMG5 were shown 
to induce degradation of reporter constructs, therefore identifying them as the NMD-
triggering features [30, 34, 42]. mRNAs encoding NMD factors have also been identified as 
NMD targets in other organisms, including SMG7 and UPF3 in Arabidopsis thaliana and SMG5 
in Drosophila melanogaster, suggesting the autoregulatory NMD mechanism may be 
evolutionarily conserved [104-106]. 
 
8. NMD factor mutations in human diseases and the therapeutic potential of modulating 
NMD activity 
As mentioned above, loss-of-function mutations in the human UPF3B gene are associated with 
diverse forms of intellectual disability (ID) [43-47]. Molecular analysis of lymphoblastoid cell 
lines (LCLs) from ID patients showed that UPF3B loss-of-function mutations cause a strong 
reduction in UPF3B mRNA and protein levels, with a concomitant increase in UPF3A protein 
levels that inversely correlates to the severity of the patients’ phenotype [107]. Transcriptome 
analysis showed that approximately 5% of the transcriptome was affected in UPF3B mutant 
patients compared to control individuals and GO term analysis showed that some 
differentially regulated transcripts are related to neuronal processes [107]. In addition, UPF3B 
ablation in primary hippocampal neurons or expression of disease-related UPF3B missense 
variants in rat neuronal stem cells resulted in altered neurite growth [59, 108]. Copy number 
variants of UPF3A, SMG6 and UPF2 are significantly associated with neurodevelopmental 
disorders [107]. Moreover, LCLs from ID patients with heterozygous deletion of UPF2 gene 
show a transcriptome profile that resembles that of UPF3B mutant patients, suggesting NMD 
deregulation as a common molecular mechanism for these neuro-developmental disorders 
[109]. Recently, a multiple congenital anomaly syndrome was found to be linked to loss-of-
function mutations in SMG9, and global expression analysis showed that LCLs from affected 
individuals have a transcriptome profile that is significantly different to that of control 
individuals [41].   
Two recent studies report that somatic mutations in the UPF1 gene are frequently 
found in pancreatic adenosquamous carcinoma (ASC) [110] and in inflammatory 
myofibroblatic tumors (IMTs) [111]. In both cases, the mutations reduce UPF1 protein levels 
and result in impaired NMD in the tumor tissue relative to adjacent normal tissue. In IMTs, it 
was proposed that downregulation of NMD activity results in increased levels of chemokines 
that would in turn promote the immune cell infiltration that is characteristic in IMTs [111]. 
 NMD can have either a protective or a harmful role in disease pathology. In cases 
where the PTC-containing transcript gives rise to a truncated protein with dominant negative 
activities, degradation of the faulty transcript by NMD supposes a beneficial role for the cell. 
There are however cases, in which expression of a truncated protein would help to ameliorate 
the phenotypic consequences of a disease-causing mutation and, in these cases, bypassing 
NMD would serve as a therapeutic approach. There have been several attempts aimed at 
using read-through therapies alone or in combination with NMD inhibition to treat genetic 
disorders (reviewed in [112]). Yet, since NMD can shape the transcriptome in different cell 
types, general inhibition of NMD may have unforeseeable side effects. An alternative would 
be to inhibit NMD in a gene-specific way, as was recently reported [113]. This study showed 
that antisense oligonucleotides (ASO) that block EJC deposition in the mRNA downstream of 
a PTC can be used to inhibit NMD in a gene-specific manner. Moreover, combination of ASO 
treatment with read-through promoting compounds restored the expression of a full-length 
protein from a PTC containing transcript [113]. Although the therapeutic value of gene-specific 
NMD inhibition still remains to be tested, it emerges as an elegant and highly specific way to 
treat diseases caused by nonsense mutations.  
 
9. Concluding remark 
As described in this review, NMD exerts important biological functions that reach beyond 
mRNA surveillance. Although we are still in the beginning of unravelling the different 
regulatory circuits in which NMD is implicated, the existing evidence suggests that NMD 
affects gene expression in a diverse range of biological contexts. The unifying principle in all 
these cases appears to be the occurrence of stop codons in mRNP environments that are not 
optimal for fast enough and/or correct translation termination, leading to the degradation of 
the respective mRNA. This “survival of the fittest mRNA” bears reminiscence to a recurring 
and fundamental concept in biology. 
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Figure legends 
 
Figure 1. Roles of NMD factors in cellular differentiation. Diagram depicting cellular 
differentiation pathways, from pluripotent stem cells to terminally differentiated cell types. 
For simplicity, only some cell types are shown. The self-renewal capacity of stem cells is 
indicated by a circular arrow. Manipulation of the levels of NMD factors has been shown to 
affect some differentiation steps and this is depicted in the scheme, along with the species or 
cell type in which it was described. Inhibition of differentiation steps is represented in red, 
whereas stimulation is shown in green. (KO) knock out; (KD) knock down; (Mm) Mus musculus; 
(hESC) human embryonic stem cells; (mNSC) mouse neural stem cells. 
 
Figure 2. Tight regulation of NMD activity is required for normal spermatogenesis. (A) 
Scheme representing a cross section of a seminiferous tubule with one Sertoli cell (SC) and 
several germ cells (GC) in their differentiation stages from spermatogonia to spermatozoa. In 
round spermatids, UPF1 is localized in chromatoid bodies (CB). (LC) Leydig cells. Panels B-E 
show schematic representations of a cross section of a seminiferous tubule in different knock 
out (KO) mice. (B) Sertoli cell-specific UPF2 KO (SC-UPF2 KO) results in testicular atrophy with 
depletion of SC and GC. Analyses of total testis showed upregulation of RNAs with one exon-
exon junction >50 nucleotides downstream of the termination codon (dEJC) [53]. (C) Early 
stage germ cell-specific UPF2 KO (GC-UPF2 KO) results in depletion of GC and testicular 
atrophy. Purified germ cells show increased levels of transcripts with long 3’ UTR [54]. (D) Early 
stage germ cell-specific UPF3A KO (GC-UPF3A KO) results in depletion of late stage GC. Purified 
germ cells show decreased levels of transcripts with dEJC [40]. (E) TDRD6 KO results in 
distorted CB structure and mislocalization of UPF1 to the perinuclear space. Depletion of 
elongated spermatids is observed and transcripts with long 3’ UTRs are upregulated in purified 
round spermatids [55]. 
 
Figure 3. NMD is part of regulatory feedback loops. (A) UPF1 and miR-128 form a mutually 
repressive circuit that locks the cells in either the stem cell state or in a differentiated state. 
In neural stem cells, NMD activity is high and it indirectly downregulates miR-128 to lock the 
cells in the undifferentiated state (dashed arrow). Upon a neurogenic signal, miR-128 is 
upregulated and it promotes neural differentiation by directly downregulating UPF1. MiR-128 
direct repression of UPF1 locks the cells in the neuronal state [56, 57]. (B) NMD and the 
unfolded protein response (UPR) regulate each other to allow a proper ER stress response. In 
unstressed cells, NMD degrades transcripts encoding components of the UPR, and prevents 
UPR activation upon innocuous stimuli. Upon strong ER stress the UPR is activated and, in 
turn, inhibits NMD to allow a robust stress-response. NMD-mediated inhibition of UPR is 
important during the termination phase, to protect the cells from stress-induced apoptosis 
[60]. (C) Chromatin target of PRMT1 (Chtop) levels are autoregulated in a homeostatic 
feedback loop by AS-NMD. Excess levels of Chtop result in binding of Chtop to its own pre-
mRNA, which promotes intron 2 retention and gives rise to a premature termination codon 
(PTC). This renders the Chtop alternatively spliced mRNA isoform susceptible to NMD, thereby 
reducing the levels of functional Chtop [100]. 
 
 
 
 
 
 
Protein 
(Hs) 
Functional description 
Homologues 
Refs. 
Sc Ce Dm Plants 
UPF1 
 Central NMD factor 
 ATP-dependent RNA helicase 
Upf1 
SMG-
2 
UPF1 UPF1 
[114] 
[115] 
 Binding platform for decay machinery [116] 
[17] 
UPF2 
 Regulates the activation and helicase
activity of UPF1
 Scaffold that brings together UPF1 and
UPF3
Upf2 
SMG-
3 
UPF2 UPF2 
[117] 
[118] 
UPF3A 
 Acts as an NMD repressor by
antagonizing the formation of a complex
between UPF2 and EJC
 Can sometimes act as a weak NMD
factor
 Up when UPF3B is low
Upf3 
SMG-
4 
UPF3 UPF3 
[40] 
[118] 
UPF3B 
 Brings together UPF1, UPF2 and the
EJC
SMG1  S/T kinase that phosphorylates UPF1 none 
SMG-
1 
SMG1 SMG1* 
[119] 
[23] 
SMG5 
 Forms a heterodimer with SMG7 and is
involved in exonucleolytic degradation of
transcripts
 Involved in UPF1 dephosphorylation
none 
SMG-
5 
SMG5 none 
[20] 
[120] 
SMG6 
 Ribonuclease required for
endonucleolytic degradation of
transcripts
none 
SMG-
6 
SMG6 none 
[15] 
[16] 
[19] 
[18] 
SMG7 
 Forms a heterodimer with SMG5 and is
involved in exonucleolytic degradation of
transcripts
Ebs1** 
SMG-
7 
none SMG7 
[20] 
[24] 
Table 1. Core NMD factors. Human (Homo sapiens, Hs) factors and their homologues in 
Saccharomyces cerevisiae (Sc), Caenorhabditis elegans (Ce), Drosophila melanogaster (Dm) 
and plants. *SMG1 homologues are present in all examined plants except Arabidopsis 
thaliana. **Dispensable for NMD in S. cerevisiae. 
